Skip to search formSkip to main contentSkip to account menu

TNFSF9 gene

Known as: TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 9, tumor necrosis factor superfamily member 9, 4-1BB-L, MOUSE, HOMOLOG OF 
National Institutes of Health

Related topics

Related topics

2 relations
CD137 antigenTNFSF8 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137+ FOXP3+ Regulatory CD4 T Cells
Key Points CD137L deficiency in myeloid APCs suppresses type 1 diabetes. CD137L deficiency in pathogenic T cells enhances their… 
2020
2020
CD137-CD137L signaling affects angiogenesis by mediating phenotypic conversion of macrophages.
BACKGROUND Angiogenesis in atherosclerotic plaque is an important factor causing plaque hemorrhage, vulnerability and rupture and… 
2012
2012
Novel transmembrane protein 126A (TMEM126A) couples with CD137L reverse signals in myeloid cells.
2011
2011
Biphasic activity of CD137 ligand‐stimulated monocytes on T cell apoptosis and proliferation
CD137L (4‐1BBL) is a member of the TNFSF and is expressed on APCs as a transmembrane protein. Reverse signaling by CD137L in… 
2008
2008
Analysis of CD137 and CD137L expression in human primary tumor tissues.
AIM To assess the expression of CD137 and CD137L in human primary tumor tissues and their potential role in tumor immunity… 
2008
2008
Prevention of lethal tumor growth and generation of long-lasting immunity in vivo using CD137L and interleukin-12 gene transfer.
In a wide range of solid tumors, overexpression of CD137L has been shown to induce tumor immunity partly due to the stimulation… 
2007
2007
CD137 ligand prevents the development of T‐helper type 2 cell‐mediated allergic asthma by interferon‐γ‐producing CD8+ T cells
Background Allergic asthma is a T‐helper type 2 (Th2) cell‐mediated chronic disease that is characterized by airway… 
2004
2004
Murine CD8 lymphocyte expansion in vitro by artificial antigen‐presenting cells expressing CD137L (4‐1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour‐reactive…
The ability to expand tumour‐infiltrating lymphocytes in vitro has been greatly enhanced by the use of antigen‐independent… 
2004
2004
Anti-CD137 monoclonal antibody promotes the direct anti-tumor effect mediated by peripheral blood-derived human dendritic cells in vitro.
CD137, a costimulatory factor of TNFR family, is expressed on activated T cells and freshly isolated mouse dendritic cells (DCs… 
2003
2003
Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity.
DNA vaccines are ideally suited for immunizing against tumor antigens because constructs can be formulated that not only encode… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)